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Abstract  
 
Background: ATP-binding Cassette (ABC) transporters have key roles in various 
physiological functions as well as providing chemical defense and stress tolerance in human 
tissues. In this study we have examined the expression pattern of all ABC proteins in 
pluripotent human embryonic stem cells (hESCs) and in their differentiated progenies. We 
paid special attention to the cellular expression and localization of multidrug transporter ABC 
proteins. 
Methods: Stem cell differentiation was carried out without chemical induction or cell 
sorting, and specialized cell types were separated mechanically. Cellular features regarding 
pluripotency and tissue identity, as well as ABC transporter expression were studied by flow 
cytomtery, immuno-microscopy and qPCR-based low-density arrays. 
Results: Pluripotent hESCs and differentiated cell types (cardiomyocytes, neuronal cells 
and mesenchymal stem cells) were distinguished by morphology, immunostaining markers 
and selected mRNA expression patt rns. We found that the mRNA expression levels of the 48 
human ABC proteins also clearly distinguished the pluripotent and the respective 
differentiated cell types. When multidrug and lipid transporter ABC protein expression was 
examined by using well characterized specific antibodies by flow cytometry and confocal 
microscopy, the protein expression data corresponded well to the mRNA expression results. 
Moreover, the cellular localization of these important human ABC transporter proteins could 
be established in the pluripotent and differentiated hESC derived samples. 
Conclusions: These studies provide valuable information regarding ABC protein 
expression in human stem cells and their differentiated offspring. The results may also help to 
obtain further information concerning the specialized cellular functions of selected ABC 
transporters.   
 
 
 
Page 3 of 37
John Wiley and Sons, Inc.
Cytometry: Part B - Clinical Cytometry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
3 
 
Introduction 
 
The ABC protein family is present from bacteria to humans, and the 48 human ABC 
proteins include several transporters, channels, as well as non-membrane proteins (1). During 
the past decades a large amount of information became available about the expression and 
function of these human proteins, while there are still numerous unresolved questions in this 
field. We have shortly summarized the recent knowledge about the human ABC proteins in 
Supplementary Table 1. 
Certain ABC transporters form a special network of chemo-defense system, as these 
ATP-dependent active transporters extrude a wide variety of substrates from the cells, 
including endo- and xenobiotics. While these ABC transporter (with a key role of 
ABCB1/Pgp, ABCC1/MRP1 and ABCG2/BCRP) proteins play an important role in 
protecting our body, they are also involved in causing multidrug resistance in cancer cells 
(2,3). One member of these multidrug transporters, ABCG2, has been shown to play a major 
role in the protection of stem cells against toxic compounds. In addition, the ABCB6 protein 
has been indicated to play a major role in the defense against toxic heme derivatives, while 
the ABCA1 protein has a key role in the extrusion of excess cellular lipid derivatives, 
especially cholesterol (see refs (4-9) ).  
Since the human embryonic stem cells (hESC) require special protection during 
development, and some of the differentiated tissues are also well protected against toxic 
agents, an important task is to follow the changes in the expression and localization of the 
ABC multidrug transporters during these early developmental processes.  
In our previous studies we have shown that the HUES9 embryonic stem cells express the 
ABCG2 protein at the cell surface (10), and this transporter has an important role in defending 
the HUES9 cells during stress conditions (5). In the current work we have examined the full 
pattern of 48 human ABC protein mRNA expression levels by qPCR-based microarray, in 
order to provide information about changes in their tissue expression patterns in 
undifferentiated and selectively differentiated hES cells. We have also followed the 
expression of selected ABC transporter proteins by flow cytometry and immunostaining 
during early human cell differentiation. In addition to provide basic information about ABC 
protein expression, these studies also allowed to examine the cellular localization of these 
transporter proteins which was not exactly known for embryonic stem cells and their 
derivates.  
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Materials and Methods 
Cell culture and differentiation  
The hES cell line HUES9 (originally provided by Dr. Douglas Melton, Harvard University) 
were maintained on mitotically inactivated mouse embryonic fibroblasts (MEF) and 
spontaneous differentiation were performed via embryoid body (EB) formation as described 
previously (11). After 6 days embryoid bodies were placed onto gelatin coated 24 well plates, 
where they attached to the surface and underwent spontaneous differentiation. The desired 
cell types were separated as follows: 
Some of the EB-outgrowths start spontaneously beating within a few days post-plating. 
These rhythmically contracting areas were isolated mechanically and hES cell-derived 
cardiomyocytes were re-plated on gelatin coated 8 well confocal chambers or harvested to 
RNA isolation. Neuronal progenitor cells with rosette-like morphology were mechanically 
isolated for generation of hES cell-derived neural cells, between days 8 and 10. These rosettes 
were able to re-attach onto gelatin coated surfaces and continue their further differentiation to 
mature neural cell types. The RNA isolation and immunostaining were performed at day 24. 
The mesenchymal stem cell like (MSCl) cells were generated and maintained as described 
previously (12). For more details see the Supplementary Methods. 
Flow cytometry 
Single cell suspensions were prepared by gentle trypsinization, and the cells were labeled in 
PBS containing 0.5% bovine serum albumin with appropriate antibodies. In all hESC samples 
an anti-mouse Sca-1 (Ly-6A/E) (FITC or PE, BD Pharmingen) antibody was employed for 
gating out the positively labeled mouse feeder cells.  
We used the following directly labeled anti-human antibodies: SSEA4-APC and PODXL-
PE (R&D Systems) for investigation of pluripotency. For indirect staining of ABC 
transporters the following monoclonal antibodies were applied: 5D3 (BD Pharmingen) for 
ABCG2, MRK16 (Alexis Biochemicals) for ABCB1, anti-Lan (OSK43 (generated and kindly 
provided by Hideo Takahashi Japanese Red Cross Osaka Blood Center, Japan) (13)) for 
ABCB6, R1 (Abcam) for ABCC1 and AB H10 (Abcam) for ABCA1 labeling. The 5D3 
labeling was performed in the presence of Ko143, a specific inhibitor of ABCG2, which 
maximizes 5D3 binding (14). Control staining with appropriate isotype-matched control 
mAbs was included. For fixation and permeabilization of the cells the Fix&Perm (Invitrogen) 
solution was used, according to the manufacturer’s instruction. Samples were analyzed by a 
BD FACSCantoII flow cytometer (Becton Dickinson Immunocytometry Systems [BDIS]). 
For more details see the Supplementary Methods. 
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Immuno-cytochemical staining 
Immunostaining of all cell types was performed as described previously (10), except the cell 
surface labeling of ABCG2 which was carried out as described by (5). For labeling of 
pluripotent and differentiation markers the following primary antibodies were applied: Oct4 
(SantaCruz), Nanog, SSEA4 and PODXL (RnD Systems) cardiac Troponin-I (Sigma), Nestin 
(Abcam), β-III Tubulin (RnD Systems) and CD-44-FITC (BD Pharmigen). The ABC 
transporters were studied by the same antibodies used for flow cytometry.  Hoechst33342 
(Invitrogen) was used for nuclear staining. The stained samples were examined by an 
Olympus FV500-IX confocal laser scanning microscope. For more details see the 
Supplementary Methods. 
Gene expression analysis 
Total RNA was isolated from the cells using the Trizol reagent (Life Technologies). RNA 
integrity was checked by standard gel electrophoresis, RNA concentration was determined by 
spectrophotometry using a NanoDrop 2000 Spectrophotometer (Thermo Scientific). Gene 
expression profiles were determined by analysing TaqMan® Low Density Arrays (TLDA 
cards, Life Technologies) designed for mesasuring pluripotency marker genes (TaqMan® 
Array Human Stem Cell Pluripotency Panel, cat. #: 4385344) or ABC transporters (TaqMan® 
Array Human ABC Transporter Panel, cat. #: 4378700). Briefly, 500 ng of total RNA was 
used to prepare cDNA samples using the Reverse Transcription System Kit (Promega), 
according to the manufacturer’s instruction. cDNA samples corresponding to 100ng of total 
RNA were combined with 2X TaqMan® Gene Expression Master Mix and loaded on one 
channel of the appropriate TLDA card; real-time PCR reactions were run on a 7900HT 
System according to the manufacturer’s protocol (Life Technologies). For data analysis, the 
DataAssist™ Software v3.0 (Life Technologies) was used. Gene expression values were 
determined by the ∆∆Ct method using multiple endogenous control genes on the TLDA cards 
(ACTB and GAPDH genes for the pluripotency array data and PRLP0 and PPIA genes for the 
ABC transporter array data). The average linkage clustering method was applied to analyze 
the expression data and to calculate Pearson’s correlation values to define distances of our 
samples sets. 
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Results 
1. Differentiation of hES cells – characterization by differentiation markers  
For studying the expression of human ABC proteins in pluripotent cells and in their 
differentiated derivatives, we have generated cardiac cells, mesenchymal-like stem cells 
(MSCls (12)) and neural cells from the HUES9 cells, by using a method of spontaneous 
differentiation, via EB formation (Supplementary Fig. 1). With this method the desired cell 
types could be generated from hESC without the addition of special chemicals, and the 
selection of the differentiated progenies was performed by enzymatic digestion and/or 
mechanical selection, without applying any drug selection or cell sorting. All the 
differentiated cell types were cultured in the same media and under similar conditions (see 
Materials and Methods). These uniform conditions were used because the expression levels 
and localization of several ABC proteins have been shown to be influenced by chemical 
inducers, selection drugs or antibiotics (see ref. (15,16)).  
When selecting various tissue types, we performed a detailed phenotypic characterization 
of the parental and differentiated cell types, in order to assure that any further analysis should 
be performed by using properly selected populations. This characterization included the 
investigation of several cell type specific markers by flow-cytometry and 
immunocytochemistry.  
As shown in Figure 1A, by flow cytometry studies we found that the pluripotent hES 
cells (HUES9) highly expressed the SSEA-4 and PODXL pluripotency markers on the cell 
surface. Using immunostaining and confocal microscopy, we could clearly show the presence 
of the nuclear pluripotency markers, Oct4 and Nanog, as well as the cellular membrane 
staining of SSEA-4 and PODXL (Fig. 1B).  
During differentiation studies, cell surface markers for MSCls were analyzed as 
described in detail in our previous work (see (12)). In all cases, immunostaining revealed 
proper separation of cells showing positive staining for representative markers of cardiac 
(cardiac troponin-cTNI), neural (neuron specific tubulin-β-III tubulin and Nestin) and 
mesenchymal (CD44) cell types (Figure 1C). 
    After this phenotypic selection and verification we have analyzed the mRNA 
expression patterns of the selected cell types by using a TLDA pluripotency array. Besides the 
differentiated cell types, the common progenies of the differentiated cells (mesenchymal, 
cardiac and neural) from 6 days old EBs were included in the further investigation. The array 
included 36 pluripotency, 19 mesoderm, 13 ectoderm, 17 endoderm and 4 trophectoderm 
markers, along with several housekeeping genes. An overview of these data (summarized in 
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supplementary table 2) is demonstrated in a heat-map (Fig. 2A), showing relative gene 
expression levels. The cluster analysis (see Methods), documented in Fig. 2B, shows close 
correlation of the mRNA expression pattern with the differentiation status of the cell samples. 
As shown, the biological parallels (for hESC and MSCl) clustered together, while the 
undifferentiated hESC samples are clearly separated from the partially differentiated sample 
(6 days EB). The mRNA clusters of the differentiated cell types are noticeably different from 
that of the hESCs and from one another and the biological replicates of the most differentiated 
cell types (the MSCl cells, after 80 days of differentiation) are located away from the 
undifferentiated cells with the longest distance in the dendrogram. As shown by the highest 
expression levels found in the pluripotency array data, the hES cells showed high levels of the 
pluripotency mRNA markers, while the derivative cells showed upregulated levels of the 
proper lineage-specific markers (Fig 2C).  
 
2. ABC transporter expression in pluripotent and differentiated hES cells – flow 
cytometry studies 
In these experiments we investigated the ABC transporter expression in the pluripotent 
and differentiated cells at the protein level. The application of specific and properly reactive 
antibodies is a crucial question in these experiments. Especially in the case of the flow 
cytometry studies, we used antibodies against extracellular epitopes to examine the expression 
and cell surface localization of ABCG2 (mAb 5D3), ABCB1 (mAb MRK16), and ABCB6 
(mAb OSK43). However, most of the antibodies recognizing human ABC transporters have 
been generated against intracellular epitopes, and in several experiments we have used such 
antibodies (see Methods). In each case, the specific protein recognition was assured by 
examining various cell types overexpressing these ABC transporters (suppl. fig 2a).   
The two major cell types in which ABC transporter expression could be studied without 
major cellular damage were the undifferentiated hES cells and the MSCs. In these cell types 
we focused on the expression of ABC multidrug or lipid transporters with key roles in cellular 
chemodefense and stress response. As shown in Fig. 3, in the case of ABCB1, ABCB6 and 
ABCG2 we used the respective antibodies recognizing extracellular epitopes, while in the 
case of ABCC1 and ABCA1 we employed antibodies generated against intracellular protein 
domains.  
Fig. 3A shows flow cytometry detection of five ABC transporters (ABCB1, ABCB6, 
ABCG2, ABCC1 and ABCA1) in hESCs under non-permabilized conditions using antibodies 
recognizing external epitopes;, while panel B of Fig. 3 shows similar measurements after 
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permeabilization of hESCs. As documented, in all cases we found a very low level expression 
in the non-permeabilized cells except ABCG2 which showed elevated level of cell surface 
expression, while a slight increase in the apparent expression of all these transporters, 
especially ABCA1 could be found in the permeabilized hESCs. Only ABCG2 expression 
level showed an apparent reduction under these conditions, showing that the 5D3 antibody 
binding was reduced by the applied fixation-permeabilization. 
Fig. 4 documents similar studies carried out with hES-derived MSCls by flow cytometry. 
In this case the expression levels of all studied transporters were negligible without 
permeabilization (Fig 4 A), but were well detectable in the permeabilized cells in the case of 
ABCB6, ABCC1, and especially of ABCA1. It is important to note that ABCG2 expression 
was not detectable in these cells, with or without permeabilization.  
In the case of ABCB1 and ABCB6 (antibodies reacting with external membrane 
epitopes) the potential expression of these proteins in intracellular membrane compartments 
may be suggested by these data.  Since the ABCC1 and ABCA1 antibodies recognize 
intracellular epitopes, the increased protein levels found in the permeabilized cells most 
probably correspond to increased general expression levels, and in this case the plasma 
membrane or intracellular membrane expression levels cannot be distinguished.  
 
3. ABC transporter expression in pluripotent and differentiated hES cells – 
immunomicroscopy studies 
Flow cytometry examinations could not be performed with vulnerable cell types such as 
cardiomyocytes and neural cells, without injuring the cells. Comparative examination of the 
hESC and hESC derived cell types by immunohistochemistry is thus an additional method to 
characterize protein expression and yield more informative cellular localization data than flow 
cytometry.  
In Fig 5 we summarize the results of the immunostaining experiments. This figure 
compiles representative data for each cell type and for the above described antibodies 
recognizing selected ABC transporters.  As shown in Supplementary Figure 2B, we have 
examined several selected cell types, overexpressing these ABC transporters, as positive 
controls (see also M&M).  
As documented in Fig. 5, in the case of ABCA1 all hESC-derived cell types showed well 
measurable expression, and in the undifferentiated hESCs and the MSCls, the expression was 
homogenously high showing both plasma membrane and cytosolic localization. In contrast, 
only a small number of cardiac and neural cells showed ABCA1 expression, and this 
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expression was mostly localized in the cytosol. In the case of ABCB1, we found measurable 
expression only in the differentiated cardiac and neural cell types, which was in agreement 
with the flow cytometry data indicating no ABCB1 expression in the undifferentiated hESCs 
and the MSCls. The ABCB6 protein was expressed ubiquitously in all of the examined cell 
types, and the expression was found in intracellular compartments.  These data are again in 
line with the flow cytometry results which also indicated intracellular expression of this 
protein. For ABCC1, a well measurable expression could be observed for most of the cell 
types, except for the cardiac cells, showing a much lower protein level. In all cases, ABCC1 
expression was detected in the plasma membrane compartment.  
As shown earlier in Fig. 3, in the undifferentiated hES cells high level of ABCG2 protein 
expression was detected on the cell surface by flow cytometry and the immunostaining 
experiments shown in Fig. 5 verified this phenomenon. In contrast, we could not detect a 
significant ABCG2 expression in the differentiated MSCl cell types and some expression 
could be detected on cardiac and neural cultures however this expression was confined to the 
border of tissues.  In Fig. 5, we have also included immunostaining data for the ABCC6 
protein, as this transporter has been indicated to play an important role in cardiac tissues 
(17,18). However, we could not detect ABCC6 expression in any of the examined hESC-
derived cell types. 
 
4. ABC protein mRNA expression in pluripotent and differentiated hES cells 
Because of the lack of reliable antibodies and staining protocols for numerous human 
ABC proteins, a systematic analysis can only be performed for the respective mRNA 
expression levels. For this purpose we used a quantitative RT-PCR technology and ABC 
protein specific microarray, and examined the same mRNA samples as used in the 
pluripotency array analysis (see Fig. 2), obtained from pluripotent hESCs and the 
differentiated cell types. A visual overview of these gene expression data is demonstrated in a 
heat-map (Fig. 6 A), while the original Ct data are presented in the Supplementary Table 3. 
When analyzing the ABC mRNA array we observed that the expression of ABC 
transporters in general showed lower mRNA expression levels than the pluripotency markers 
(average Ct (ABC) = 33,6 ± 2,8; average Ct (pluri) = 21,6 ± 7,6), as compared to the similar 
level measured for the expression of the housekeeping genes. Since membrane protein 
expression usually requires long term expression of relatively smaller amount of proteins, this 
result was in accordance with our expectations. 
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Cluster analysis based on ABC protein expression patterns is shown in Fig 6B. 
Remarkably, clustering based on ABC transporter profiles was found to be similar to the 
hierarchy defined by pluripotency markers (see Fig. 2), indicating that all the examined cell 
types have characteristic expression patterns (fingerprints) for the ABC proteins, depending 
on the cell maturation status. As shown in Fig 6C, some of the ABC proteins showed similar 
(medium) level of expression in all cell types (Fig 6C left panel), although most of these ABC 
proteins are not well described transporters, and some are not even membrane proteins (see 
Suppl. table 1). These data suggest a role of these ABC proteins in the general maintenance 
of cellular homeostasis.  
In the following analysis, we focused on the recognized ABC membrane transporters, 
and excluded those proteins which showed high Ct values, indicating extremely low or no 
expression (Fig 6C right panel). We compared the relative expression of ABC transporter 
mRNAs in differentiated cells to those in undifferentiated hES cells (Supplementary table 
4).  
As shown in Fig7 and presented in supplementary table 4, we found that most of the 
ABC transporters were expressed at significantly higher level (although in different 
magnitudes, see Fig 7A and B) in the differentiated cell types than in the pluripotent hESCs.  
When analyzing the cell-type dependent expression, we found that several ABC transporter 
mRNA levels showed large increase in differentiated progenies. These included the 
expression of ABCA8, ABCC3, ABCC9, and ABCG1. In contrast, there were several 
transporter mRNA expression levels characteristic for certain cell types: changes of ABCB1 
and ABCC6 expressions were higher in cardiac cells and ABCA4 was higher in neural cells 
compared to hESC (Fig 7A). Note, that the only ABC transporter which showed a decreased 
expression level in all differentiated cell types was ABCG2 (Fig 7B).   
 This cell type-specific expression indicates a possible role of these proteins in the 
differentiated tissues and allows a further characterization of their physiological roles.  
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Discussion 
ATP-binding Cassette (ABC) transporters play an important role in various physiological 
functions, maintain cellular homeostasis, and provide defense mechanism against toxic endo- 
and xenobiotics. These ABC transporters work in a general defense network system, having 
overlapping functions and substrate specificity. Based on their promiscuous recognition of 
toxic agents, they can functionally substitute each other. While many of the ABC multidrug 
transporters also have broad tissue distribution, their expression levels may provide a tissue-
specific “fingerprint”, corresponding to special metabolic or other cellular functions, as well 
as tolerance against stress and drugs. 
In this study we have examined the protein level and cellular localization of the major 
multidrug transporters, as well as the mRNA expression pattern of all 48 ABC proteins in 
pluripotent human embryonic stem cells and in their selected, differentiated progenies. In 
order to investigate the human ABC transporter expression “fingerprint” in differentiating 
cells, we have used and characterized an experimental system involving four human cell types 
of isogenic origin. We have cultured human pluripotent hESCs, and in a spontaneous 
differentiation model generated well separable differentiated cell types, including cardiac 
cells, neural cells and MSC-like cells. The major advantage of this system is that the hES cells 
and the differentiated progenies have the same genetic background and cell differentiation did 
not involve major changes in the culturing conditions. 
In these experiments first we examined pluripotency and tissue-specific marker protein 
expression in the selected cell types by flow cytometry and immunostaining. We have also 
carried out the investigation of the mRNA expression pattern of a wide range of pluripotency 
and differentiation markers by using RT-PCR based quantitative arrays. These studies 
established a proper characterization of the respective cell types.  
When looking for ABC protein expression, we found that the mRNA expression levels of 
all the 48 human ABC proteins also clearly distinguished the pluripotent and the respective 
differentiated cell types. According to recent studies, distinct ABC protein patterns were 
observed when hESCs (HES2 and HES3) were compared to hematopoietic stem cells, 
unrestricted somatic stem cells and mesenchymal stem cells (19). It has also been shown that 
mRNA expression levels are different in hESCs and hESC-derived hMSCs (20). However 
none of these studies have investigated the ABC transporter expression at protein level. In 
order to perform a detailed characterization, we selected several key ABC transporters 
involved in multidrug resistance, providing defense against stress conditions, and modulating 
cellular lipid metabolism. These transporters were examined by using well characterized 
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specific antibodies both in flow cytometry and confocal microscopy experiments. This way 
the cellular expression pattern and also the subcellular localization of these important human 
ABC transporters could be established in the pluripotent and differentiated hES cell derived 
samples. It is important to note that the obtained ABC transporter protein expression data 
closely corresponded to the respective mRNA expression results.  
During our investigations, we found that the most prevalent multidrug transporter in the 
undifferentiated hES cells, in accordance with previous data, was the ABCG2/BCRP protein. 
This protein is expressed on the cell surface and, although this expression is heterogeneous, 
may significantly contribute to the defense mechanisms in pluripotent stem cells (sees refs. 
(10,19-22)). Another multidrug transporter found at low levels in the undifferentiated cells 
was ABCC1 (on the cell surface), while we could not detect ABCB1/MDR1 in this cell type. 
Two other ABC transporters found to be expressed in the hES cells were ABCA1, an 
important player in lipid/cholesterol extrusion, and ABCB6, a potential player in protecting 
against toxic heme derivatives. Interestingly, this transporter, noted to be also in the plasma 
membranes of various cells (23,24), showed only intracellular expression in all cell types 
examined here.    
In the human ES-derived neural cells we observed high level expression for ABCB6 and 
ABCC1, and in certain cell regions for that of ABCA1 and ABCB1. In the cardiomyocytes 
high level expression of ABCB6 and lower levels for ABCB1 and ABCA1 were observed. 
Interestingly, certain cells in the external regions of cardiac and neural tissue samples also 
showed ABCG2 expression. In the MSCs a predominant, but mostly intracellular expression 
was observed for ABCA1, ABCB6 and ABCC1, while there was no measurable expression 
for ABCB1 or ABCG2. As of note, we did not find any significant ABCC6 expression at 
protein level in any of the cell types examined here.   
As a summary, these studies may provide important information for a selective ABC protein 
expression pattern in human stem cells and in their differentiated offsprings. However, further 
studies are needed for the establishment of specialized inter-tissue and inter-organ 
distribution, as well as for the cellular functions of the key human ABC transporters during 
early human development.   
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Figure Legends 
 
Figure 1. Characterization of HUES9 cells and their derivates by following the expression of 
selected proteins.  
(A) Investigation of the pluripotent state of HUES9 cells by flow cytometry. More than 90% 
of the cells show cell-surface SSEA4 and PODXL expression. M1: cell population with 
marker positivity was gated based on the relevant isotype-matched control mAbs. 
(B) Investigation of the pluripotent state of HUES 9 cells by immunomicroscopy. HUES 9 
cells were grown on MEF feeder cells for two days in eight-well chambers for confocal 
microscopy. Co-culture of HUES9 and feeder cells were fixed, permeabilized and stained 
with the antibodies recognizing the Nanog (red), Oct4 (green), SSEA4 (green) and PODXL 
(green) markers. Nuclei were counterstained with Hoechst33342 (blue). Nanog and Oct4 
transcription factors showed nuclear localization, while SSEA4 and PODXL cell surface 
markers localized in plasmamembrane.  
(C) Investigation of the differentiated forms of HUES9 cells by immunomicroscopy. HUES9-
derived cell types were differentiated as described in Materials and Methods and were 
transferred mechanically into eight-well chambers for confocal microscopy. The samples 
were fixed, permeabilized and stained with antibodies recognizing specific proteins for each 
cell type; cTNI (green) for cardiac, β- III tubulin (green) and Nestin (red) for neural and CD44 
(green) for mesenchymal cell type. Nuclei were counterstained with Hoechst33342 (blue). 
 
Figure 2. TLDA analysis of differentiation status of HUES9 cells and their differentiated 
offspring 
(A) Heat map representation of human pluripotency marker gene mRNA expressions in 7 
samples of 4 cell types (hESCs a and b, cardiac, neural and MSCs a and b) and the 6 days old 
EB culture (the common progenitors of differentiated cell types). The pluripotency genes are 
shown on the y-axis, the 7 samples are ordered on the x-axis with biological replicates (“a” 
and “b”). The color code ranges from high (dCt = -6, light red) through medium (black), to 
low (dCt = 26, light green) levels of gene expression relative to selected housekeeping genes.  
(B) Hierarchical clustering of 7 samples allowing a separation based on differentiation status 
of the samples.  
(C) The highest gene expressions (5<Ct>15) for each cell type showing the proper 
characteristics for a given differentiation status.  
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Figure 3. Flow cytometry analysis of ABC transporter expression in hES cells. 
Single cell suspensions from HUES9 cells were obtained as described in Materials and 
Methods. Non-viable cells were gated out by 7AAD staining. Monoclonal antibodies specific 
for ABCB1, ABCB6, ABCG2, ABCC1 and ABCA1 were used to detect transporter 
expression (A) in intact cells (without fixation and permeabilization) and (B) in fixed and 
permebealized cells (for details see Materials and Methods). R1: cell population with marker 
positivity was gated based on the relevant isotype-matched control mAbs; MFI: mean 
fluorescence intensity. 
 
Figure 4. Flow cytometry analysis of ABC transporter expression on MSCl cells. 
Single cell suspensions from MSCl cells were obtained by gentle trypsinization. Non-viable 
cells were gated out by 7AAD staining. Monoclonal antibodies specific for ABCB1, ABCB6, 
ABCG2, ABCC1 and ABCA1 were used to detect transporter expression (A) on intact cells 
(without fixation and permeabilization) and (B) in fixed and permeabilized cells (for details 
see Materials and Methods). R1: c ll population with marker positivity was gated based on 
the relevant isotype-matched control mAbs; MFI: mean fluorescence intensity. 
 
Fig. 5 Immuncytochemical detection of ABC transporters in HUES9 cells and their 
derivatives. 
HUES 9 cells were grown on MEF feeder cells for two days in eight-well chambers and 
HUES9-derived cell types were differentiated as described in Materials and Methods and 
were transferred mechanically into eight-well chambers for confocal microscopy. The 
samples were stained with specific antibodies to visualize ABCA1, ABCB1, ABCB6, 
ABCC1, ABCG2 and ABCC6 proteins (red) as described in the “Materials and methods” 
section. Nuclei were counterstained with Hoechst33342 (blue). Stained samples were 
examined by an Olympus FV500-IX confocal laser scanning microscope.  
 
Figure 6. TLDA analysis of ABC protein gene expression in HUES9 cells and their 
differentiated offspring 
(A) Heat map representation of human ABC protein gene expressions in 7 samples of 4 cell 
types (hESCs a and b, cardiac, neural and MSCls a and b) and the 6 days old EB culture (the 
common progenitors of differentiated cell types). The ABC genes are shown on the y-axis, the 
7 samples are ordered on the x-axis with biological replicates (“a” and “b”). The color code 
ranges from high (dCt = 4, light red) through medium (black), to low (dCt = 14, light green) 
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gene expression relative to selected housekeeping genes. (B) Hierarchical clustering of 7 
samples allowing a separation based on differentiation status of samples. (C) The listed 
highest ABC gene expressions (27<Ct>32, bold) and lowest gene expressions (Ct>38, 
normal) were common for each cell type showing universal expression pattern for certain 
ABC proteins.   
 
Figure 7. Relative gene expressions of ABC transporters in hESC derived cell types as 
compared to undifferentiated cells. 
The relative gene expression levels of each transporter in hESCs are set at 1 and the fold 
differences in expression are presented on the graph. 
 
Supplementary table 1. Summary of human ABC proteins  
For more information see refs (http://humanabc.4t.com/main.htm, (9,25-28)) 
Supplementary table 2. List of pluripotency gene expression data 
The Ct values are given for each cell type. Pluripotency markers (black), mesoderm markers 
(green), ectoderm markers (blue), endoderm markers (orange), trophectoderm markers 
(brown), housekeeping genes (italic, black), transcription factors (bold).  
Supplementary table 3. List of ABC protein gene expression data 
The Ct values are given for each cell type. The value of 40 indicates the lack of 
detection/expression of the corresponding mRNA. 
Supplementary table 4. ABC transporter expression changes during differentiation towards 
cardiac, neural and mesenchymal cell types. 
Supplementary Figure 1. Differentiation of hES cells via embryoid body system 
An outline of the protocol used for the differentiation of human ESCs to cardiac, neural and 
mesenchymal cell types. 
Supplementary Figure 2. Immunostaining for detection of ABC transporters  
(A) Single cell suspensions from positive cell types were obtained by gentle trypsinization. 
Non-viable cells were excluded by 7AAD staining. Monoclonal antibodies specific for 
ABCB1, ABCB6, ABCG2, ABCC1 and ABCA1 were used to detect transporter expression 
as described in Materials and Methods. R1: cell population with marker positivity was gated 
based on the relevant isotype-matched control mAbs 
 (B)The positive cell types were passaged into eight-well chambers for confocal microscopy. 
The samples were stained with specific antibodies to visualize ABCA1, ABCB1, ABCB6, 
ABCC1, ABCG2 and ABCC6 proteins (green) as described in the “Materials and methods” 
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section. Nuclei were counterstained with Hoechst33342 (blue). Stained samples were 
examined by an Olympus FV500-IX confocal laser scanning microscope.  
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10-100x higher expression relative to hESC
Cardiac Neural MSC
ABCA8 83.6 ABCC9 87.8 ABCC9 99.2
ABCG1 44.7 ABCA8 29.6 ABCC3 90.2
ABCC9 33.9 ABCG1 16.8
ABCC3 16.3 ABCA4 16.0
ABCC6 13.8
ABCB1 11.9
2-10x higher expression relative to hESC
Cardiac Neural MSC
ABCC2 7.77 ABCA5 9.04 ABCA5 7.89
ABCD1 7.39 ABCC7 6.40 ABCD1 7.61
ABCC7 5.98 ABCC2 5.62 ABCB9 7.10
ABCB4 5.71 ABCD1 5.45 ABCC10 6.48
ABCA7 5.58 ABCB4 5.23 ABCA1 6.17
ABCC10 5.58 ABCB9 4.65 ABCB2 4.96
ABCA5 5.48 ABCD3 4.35 ABCA2 5.62
ABCB9 5.16 ABCA1 4.21 ABCG1 5.37
ABCA4 5.06 ABCA2 4.00 ABCB3 3.35
ABCA2 3.86 ABCB1 3.47 ABCB8 2.62
ABCB8 4.76 ABCC3 3.45 ABCC4 2.01
ABCG4 2.27 ABCA3 3.28
ABCA1 2.22 ABCC10 3.00
ABCC1 2.70
ABCC8 2.45
ABCA7 2.37
ABCC4 2.29
ABCC5 2.25
ABCB8 2.15
<2 or lower expression relative to hESC
Cardiac Neural MSC
ABCA3 1.98 ABCC6 1.91 ABCB10 1.89
ABCC8 1.95 ABCB10 1.82 ABCD3 1.82
ABCC5 1.79 ABCB6 1.63 ABCC1 1.80
ABCD3 1.69 ABCG4 1.59 ABCA8 1.78
ABCD4 1.43 ABCB7 1.33 ABCB1 1.70
ABCC1 1.31 ABCB2 1.26 ABCC5 1.57
ABCB6 1.27 ABCB3 1.26 ABCC2 1.41
ABCB3 1.19 ABCD4 0.77 ABCB6 1.05
ABCB10 0.96 ABCG2 0.14 ABCG4 0.95
ABCB7 0.87 ABCA4 0.71
ABCB2 0.74 ABCD4 0.63
ABCC4 0.32 ABCB7 0.48
ABCG2 0.23 ABCC7 0.41
ABCA7 0.38
ABCB4 0.33
ABCC6 0.32
ABCC8 0.27
ABCA3 0.12
ABCG2 0.07
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Supplementary methods 
 
Cell cultures and differentiation  
 
ABCA1 overexpressing HEK 293 (HEK 293-A1), ABCC1 overexpressing HEK 293 (HEK 
293-A1), ABCC6 overexpressing MDCK (MDCK-C6), and HeLa (endogenously expressing 
ABCB6) cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% of fetal calf serum, 1% of L-Glutamine, and 1% of 
penicillin/streptomycin (Life Technologies) and were used as positive controls for 
immunostainings of respective ABC transporter proteins. HCT-15, ABCA1, ABCB1 and 
ABCC1 overexpressing HL60 cell lines (HL60-ABCA1, HL60-ABCB1 and HL60-ABCC1 
respectively) were cultured in RPMI1640 Medium, supplemented with 10% of fetal calf 
serum, 1% of L-Glutamine, and 1% of penicillin/streptomycin (Life Technologies) and was 
used as a positive control cell line for respective ABC transporter proteins stainings. 
HUES9 cells were cultured on a feeder layer of mitotically inactivated mouse embryonic 
fibroblasts (mitomycin-C (Sigma) and Millipore – CF1) on tissue culture 6- well plates 
(Nunc). The culture medium consisted of 15% Knockout Serum Replacement (Gibco), 80% 
Knockout Dulbecco Modified Eagle Medium (Gibco), 1 mM Glutamax-I (Gibco), 0.1 mM 
beta-mercaptoethanol, 1% nonessential amino acids, and 4 ng/mL human fibroblast growth 
factor (Invitrogen). Cells were re-plated every second day on fresh feeder layer by enzymatic 
dissociation with 0,025% trypsin-EDTA (Invitrogen).  
Differentiation of Human Embryonic Stem Cells (HUES9) 
Spontaneous differentiation of the HUES9 cells was performed via embryoid body (EB) 
formation system in suspension. Undifferentiated cells were passaged enzymatically with 
collagenase-IV and were transferred to Poly-2 Hydroxyethyl-methacrylate (Sigma-Aldrich) 
treated Petri dishes; therefore the spontaneous aggregation of cells and embryoid body 
formation could be obtained. EBs were cultured in differentiation medium consisting of Ko 
DMEM supplemented with 20% non heat inactivated fetal bovine serum, 1% nonessential 
amino acids, 1mML-glutamine, and 0.1mM beta-mercaptoethanol (Invitrogen) for six days, 
medium was changed daily. In case of neuronal differentiation, similarly to undifferentiated 
cell culture medium, 4 ng/ml bFGF was added to the culture media during EB formation. 
After 6 days, the embryoid bodies were placed onto gelatin-coated 24- well plates, where they 
continued a further spontaneous differentiation process in D-MEM supplemented with 10% of 
fetal calf serum, 1% of L-Glutamine, medium was changed on every other day. After few 
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days of culturing under the aforementioned conditions several cell types were formed in the 
gelatin-coated culture dishes, including cardiomyocytes, neuronal progenitors and fibroblast-
like cells. These cells were identified by morphological signs under phase contrast light 
microscope and mechanically passaged for further propagation in D-MEM supplemented with 
10% of fetal calf serum, 1% of L-Glutamine. 
 
Flow cytometry and immuno –cytochemical labeling 
For flow cytometric analysis single cell suspensions were split into two portions. First 
portions of cells remained intact and were labeled in PBS containing 0.5% bovine serum 
albumin with appropriate antibodies. The second samples were fixed and permeabilized by 
the Fix&Perm (Invitrogen) solution according to the manufacturer’s instruction before 
staining procedure. The labeling was accomplished with specific antibodies listed below in 
the table. In all hESC samples an anti-mouse Sca-1 (Ly-6A/E) (FITC or PE, BD Pharmingen) 
antibody was employed for gating out the positively labeled mouse feeder cells. Non-viable 
cells were excluded by 7AAD staining. Samples were analyzed by a BD FACSCantoII flow 
cytometer (Becton Dickinson Immunocytometry Systems [BDIS]), equipped with a 488 nm 
diode laser (emission filters: 585/42 nm for PE; 530/30 for FITC, 670LP for 7AAD) and a 
633 nm He-Ne laser (emission filters: 660/20 for APC) with BD FACSDiva 6.1.2 Software 
(BDIS). 
For confocal microscopy the cells were seeded onto eight-well Nunc Lab-Tek II Chambered 
Coverglass (Nalge Nunc International), and fixed with 4% paraformaldehyde in Dulbecco's 
modified PBS (DPBS) or Fix&Perm A solution for 15 min at room temperature. Occasionally 
5 min methanol treatment was used (see the Table). Following further washing steps with 
DPBS, nonspecific antibody binding was blocked for 1h at room temperature in blocking 
solution (DPBS containing 2mg/ml bovine serum albumin,1% fish gelatin, 5% goat serum) 
and with (Complete) or without 0.1% Triton-X 100 (Complete wo Tx) or Fix&Perm B 
solution. The cells were then incubated for 1 h at room temperature with specific monoclonal 
antibodies in proper blocking solutions. After washing with DPBS, the samples were 
incubated for 1 h at room temperature with secondary antibodies. After removing secondary 
antibody solutions and washing steps Hoechst33342 (Invitrogen) was used for nuclear 
staining. 
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Table of antibodies: 
Primary antibody Manufacturer Dilution Secondary 
antibody 
Labeling methods 
FACS      
Sca-1 (Ly-6A/E) 
FITC or PE 
BD Pharmingen 1:25 - Intact 
SSEA4-APC R&D Systems 1:50 - Intact 
PODXL-PE  R&D Systems 1:10 - Intact 
Anti ABCG2 
5D3-CD338 
BD Pharmingen 1:125 Mouse IgG2b-PE Intact+Ko143 or 
Fix&Perm+Ko143 
Anti ABCB1 
MRK16  
Alexis 
Biochemicals 
1:100 Mouse IgG2a-PE Intact or Fix&Perm 
Anti-Lan  
clone: OSK43 
Provided by H. 
Takahashi 
1:70 IgG+M-A488 or 
PE 
Intact or Fix&Perm 
Anti ABCC1  
clone: MRPr1 
Abcam 1:25 Rat IgG2a-PE Intact or Fix&Perm 
Anti-ABCA1 
clone:AB.H10 
Abcam 1:50 Mouse IgG1-PE Intact or Fix&Perm 
Immuncytochemistry      
Anti ABCG2 
5D3-CD338 
BD. 
Pharmingen 
1:250 Mouse IgG2b-PE Fix&Perm +Ko143 
Anti ABCB1 
MRK16  
Alexis 
Biochemicals 
1:100 Mouse IgG2a-PE 4%PFA 
Complete wo Tx 
Anti-Lan 
clone: OSK43 
Provided by H. 
Takahashi 
1:100 IgG+M-A488 or 
PE 
Fix&Perm 
Anti ABCC1  
clone: MRPr1 
Abcam 1:25 Rat IgG2a-PE 4%PFA+ 5 min 
methanol 
Complete 
Anti-ABCA1 
clone:AB.H10 
Abcam 1:200 Mouse IgG1-PE Fix&Perm  
Anti ABCC6 M6II-7 Pierce 
Antibodies 
1:100  Rat IgG2a-A488 4%PFA +5 min 
methanol Complete 
Oct4  SantaCruz 1:50 Mouse IgG-A488 4%PFA 
Complete  
Nanog RnD Systems 1:10 Goat-cy3 4%PFA 
Complete 
SSEA4 RnD Systems 1:50 Mouse IgG-A488 4%PFA 
Complete wo Tx 
PODXL RnD Systems 1:10 Mouse IgG-A488 4%PFA 
Complete wo Tx 
cardiac Troponin-I  Sigma 1:300 Mouse IgG-A568 4%PFA 
Complete  
β-III Tubulin RnD Systems 1:2000 Mouse IgG-A488 4%PFA 
Complete 
CD-44-FITC  BD Pharmigen 1:10 - 4%PFA 
Complete wo Tx 
Nestin  Abcam 1:250 Rabbit IgG-A564 4%PFA 
Complete 
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